Search for: "M & M Label Company, Inc." Results 301 - 320 of 573
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Jan 2013, 1:41 pm by Rebecca Tushnet
In an accident, and the guy with the tie says ‘let's not get our insurance companies involved. [read post]
30 Oct 2012, 4:00 am by Terry Hart
The Copyright Act provides that copyright protection exists in all “original works of authorship fixed in any tangible medium of expression ”It is well established that labels are subject to copyright protection, if the label manifests the necessary modicum of creativity. [read post]
30 Oct 2012, 4:00 am by Terry Hart
Those cases generally rely on an assertion of copyright protection over the goods’ packaging or labels, rather than the good itself. [read post]
26 Sep 2012, 10:18 am
"Just like snowflakes and fingerprints, no two lip prints are the same," Judge Miranda M. [read post]
7 Sep 2012, 9:41 am
Last week Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson on Thursday announced a $181 million settlement with 36 states and the District of Columbia over charges of marketing anti-psychotic drugs for non-approved uses. [read post]
2 Sep 2012, 3:20 pm
Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, agreed Thursday to pay $181 Million to settle cases brought by 36 states and the District of Columbia alleging illegal marketing of its anti-psychotic drugs for off-label, non-approved uses. [read post]
2 Sep 2012, 3:20 pm
Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, agreed Thursday to pay $181 Million to settle cases brought by 36 states and the District of Columbia alleging illegal marketing of its anti-psychotic drugs for off-label, non-approved uses. [read post]
27 Jul 2012, 12:40 pm by Bexis
even if everything that the company allegedly said or did was entirely truthful. [read post]
7 Jul 2012, 5:21 am
FSIS, ODA, and the company have not received reports of illesses due to consumption of these products. [read post]
7 Jul 2012, 5:12 am
FSIS, ODA, and the company have not received reports of illesses due to consumption of these products. [read post]
5 Jun 2012, 1:22 pm by Mark Zamora
Ethicon plans to discontinue or change its marketing materials as needed and revise product labeling limiting the use of certain products to abdominal procedures.Here is the letter from the company's reps:Ethicon has advised FDA that it will stop commercializing the GYNECARE TVT SECUR™ system, GYNECARE PROSIMA™ Pelvic Floor Repair System, GYNECARE PROLIFT™ Pelvic Floor Repair System, andGYNECARE PROLIFT+M™ Pelvic Floor Repair System in the… [read post]